Generics and Biosimilars in Central and Eastern Europe

25-26 Jun 2013 at InterContinental Warsaw, Warsaw, Poland

Academic

Submit new post
Thank you for posting.
Share it:
More

From 9am to 3:30pm.

Summary:

Focusing on opportunities and challenges, senior directors, partners and board members will discuss trends in generic and biosimilar development, manufacturing and commercialisation.

Description:

Attend to benefit from:

A detailed overview of the generics and biosimilars landscape in CEE, including a macro-economic outlook on the region: Pinpoint key trends in the hottest markets – Poland, Slovakia and Ukraine.

Useful insights into the complex legal and regulatory framework: Ensure your company is fully prepared to tackle upcoming changes.

Learning about various partnering strategies, their benefits and ground-breaking examples of effective International co-operation.

An excellent opportunity for international companies to learn how to access the market in CEE and be commercially successful.

A review of differentiation strategies for generics, focusing on super generics.

Price: €1413.27

Artists / Speakers: Vladimir Zah, Nicola Travierso, Agnieszka Skonieczna, Natalia Salamova, Federico Pollano, Iris Margraf, Alex Kudrin, Oleksandr Kryuk, Ranjith Gopinathan, Milosz Gruca, Klaus Martin, Rok Hren, Vojtěch Mészáros, Alan Sheppard.

When
From: June 25, 2013 00:00
To: June 26, 2013 23:59
Where

InterContinental Warsaw, Emilii Plater 49, 00-125, Warsaw, Poland

Category

Academic

External link

Submitted by:

evvnt Platform

Are you the organizer?

Get in touch